Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Appointed director

Hepion Pharmaceuticals, Inc. (CTRV) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/20/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
07/05/2022 3 Reddi Anand (Director) has filed a Form 3 on Hepion Pharmaceuticals, Inc.
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2021 4 Foster Robert T (CEO, CSO and Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 1,900,000 options to buy @ $1.7, valued at $3.2M
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2021 4 Block Timothy M. (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 200,000 options to buy @ $1.7, valued at $340k
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Wijngaard Peter (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Bought 10,000 shares @ $2.2, valued at $22k
02/18/2021 4 Foster Robert T (CEO and Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Bought 20,000 shares @ $2, valued at $40k
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2020 4 Wijngaard Peter (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Bought 20,000 shares @ $1.91, valued at $38.2k
12/08/2020 4 Foster Robert T (CEO and Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Bought 25,000 shares @ $1.5767, valued at $39.4k
12/02/2020 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Bought 7,000 shares @ $1.53, valued at $10.7k
12/01/2020 4 JACOB GARY S (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Bought 12,000 shares @ $1.66, valued at $19.9k
11/30/2020 4 Cavan John T (CFO) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Bought 4,500 shares @ $1.62, valued at $7.3k
08/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
04/07/2020 4 ADAMS THOMAS PHD (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 60,000 options @ $1.63, valued at $97.8k
04/07/2020 4 Block Timothy M. (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 60,000 options @ $1.63, valued at $97.8k
04/07/2020 4 Lippa Arnold (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 60,000 options @ $1.63, valued at $97.8k
04/07/2020 4 BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 60,000 options @ $1.63, valued at $97.8k
04/07/2020 4 Foster Robert T (CEO and CSO) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 380,000 options @ $1.63, valued at $619.4k
04/07/2020 4 JACOB GARY S (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 60,000 options @ $1.63, valued at $97.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy